Theravance (THRX)

Add to Watchlists Create an Alert
36.24 -0.54  -1.47%   NASDAQ May 24, 8:00PM BATS Real time Currency in USD

Theravance Cash from Financing TTM:

481.70M for March 31, 2013
View Full Chart

Theravance Cash from Financing TTM Chart

    Theravance Historical Cash from Financing TTM Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 481.70M
    Dec. 31, 2012 236.31M
    Sept. 30, 2012 232.00M
    June 30, 2012 220.89M
    March 31, 2012 16.41M
    Dec. 31, 2011 25.60M
    Sept. 30, 2011 156.09M
    June 30, 2011 156.16M
    March 31, 2011 148.91M
    Dec. 31, 2010 231.24M
    Sept. 30, 2010 101.71M
    June 30, 2010 101.87M
    March 31, 2010 100.66M
    Dec. 31, 2009 11.59M
    Sept. 30, 2009 8.682M
       
    June 30, 2009 9.85M
    March 31, 2009 11.14M
    Dec. 31, 2008 173.12M
    Sept. 30, 2008 174.58M
    June 30, 2008 173.21M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro

    About Cash From Financing (TTM)

    Definition: Cash from Financing

    Learn More

    Get data for

    THRX Cash from Financing TTM Benchmarks

    Companies
    Amicus Therapeutics 17.80M
    Elan -190.20M
    Biogen Idec -699.64M

    THRX Cash from Financing TTM Rankings

    Overall 96th percentile
    296 of 8011
    Sector 97th percentile
    14 of 687 in Healthcare
    Industry 99th percentile
    1 of 248 in Biotechnology

    THRX Cash from Financing TTM Range, Past 5 Years

    Minimum 8.682M Sep 2009
    Maximum 481.70M Mar 2013
    Average 138.59M